| Authors: |
Laursen MF; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Combes F; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Gudjonsson A; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Bjerkan L; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Parot J; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Tesfaye DY; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Pettersson FJ; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Molska A; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Visweswaran GRR; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Labbé GM; Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Draper SJ; Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Borgos SE; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Bogen B; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Braathen R; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway. Electronic address: ranveig.braathen@medisin.uio.no. |
